Bringing a wealth of experience from various sectors, the fund manager has successfully executed over 30 deals, primarily in technology and healthcare. With a strong focus on the European and North American markets, their strategic style blends an operator-first approach with thematic investing. Notable exits include several high-profile IPOs, showcasing a consistent ability to identify and nurture growth opportunities from early stages to maturity. Their data-driven decision-making enhances portfolio performance and aligns with emerging market trends.
Shanghai Zhangjiang Science Contacts Information